| Symbol |
Name |
|
A1BG
|
alpha-1-B glycoprotein
|
|
AAAS
|
achalasia, adrenocortical insufficiency, alacrimia
|
|
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2
|
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCB5
|
ATP-binding cassette, sub-family B (MDR/TAP), member 5
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCF1
|
ATP-binding cassette, sub-family F (GCN20), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACAD9
|
acyl-CoA dehydrogenase family, member 9
|
|
ACAN
|
aggrecan
|
|
ACAT1
|
acetyl-CoA acetyltransferase 1
|
|
ACAT2
|
acetyl-CoA acetyltransferase 2
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
ACPP
|
acid phosphatase, prostate
|
|
ACSL4
|
acyl-CoA synthetase long-chain family member 4
|
|
ACTL7A
|
actin-like 7A
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM29
|
ADAM metallopeptidase domain 29
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADCY5
|
adenylate cyclase 5
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADK
|
adenosine kinase
|
|
ADM
|
adrenomedullin
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AEBP1
|
AE binding protein 1
|
|
AFF1
|
AF4/FMR2 family, member 1
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AHSP
|
alpha hemoglobin stabilizing protein
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIF1
|
allograft inflammatory factor 1
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AIMP2
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AIRE
|
autoimmune regulator
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
|
AKR1C1
|
aldo-keto reductase family 1, member C1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT1S1
|
AKT1 substrate 1 (proline-rich)
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
AKTIP
|
AKT interacting protein
|
|
ALAD
|
aminolevulinate dehydratase
|
|
ALB
|
albumin
|
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2
|
|
ALDH5A1
|
aldehyde dehydrogenase 5 family, member A1
|
|
ALDH7A1
|
aldehyde dehydrogenase 7 family, member A1
|
|
ALDOB
|
aldolase B, fructose-bisphosphate
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALMS1
|
Alstrom syndrome protein 1
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMH
|
anti-Mullerian hormone
|
|
AMPD1
|
adenosine monophosphate deaminase 1
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANP32C
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member C
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ANXA1
|
annexin A1
|
|
ANXA13
|
annexin A13
|
|
ANXA2
|
annexin A2
|
|
ANXA5
|
annexin A5
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APBB1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65)
|
|
APC
|
adenomatous polyposis coli
|
|
APCS
|
amyloid P component, serum
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APLN
|
apelin
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA2
|
apolipoprotein A-II
|
|
APOA4
|
apolipoprotein A-IV
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP4
|
aquaporin 4
|
|
AQP5
|
aquaporin 5
|
|
AQP9
|
aquaporin 9
|
|
AR
|
androgen receptor
|
|
ARAF
|
A-Raf proto-oncogene, serine/threonine kinase
|
|
AREG
|
amphiregulin
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
ARID5B
|
AT rich interactive domain 5B (MRF1-like)
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
|
ARRB1
|
arrestin, beta 1
|
|
ARRB2
|
arrestin, beta 2
|
|
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASIC2
|
acid sensing (proton gated) ion channel 2
|
|
ASIC3
|
acid sensing (proton gated) ion channel 3
|
|
ASNS
|
asparagine synthetase (glutamine-hydrolyzing)
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATF1
|
activating transcription factor 1
|
|
ATF3
|
activating transcription factor 3
|
|
ATF4
|
activating transcription factor 4
|
|
ATF5
|
activating transcription factor 5
|
|
ATF6
|
activating transcription factor 6
|
|
ATG12
|
autophagy related 12
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATG5
|
autophagy related 5
|
|
ATIC
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4
|
|
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
|
|
ATP8B1
|
ATPase, aminophospholipid transporter, class I, type 8B, member 1
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATRIP
|
ATR interacting protein
|
|
ATXN1
|
ataxin 1
|
|
AURKA
|
aurora kinase A
|
|
AURKAIP1
|
aurora kinase A interacting protein 1
|
|
AURKB
|
aurora kinase B
|
|
AVP
|
arginine vasopressin
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
B2M
|
beta-2-microglobulin
|
|
B3GALT5-AS1
|
B3GALT5 antisense RNA 1
|
|
B3GNT8
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8
|
|
BAALC
|
brain and acute leukemia, cytoplasmic
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BACE2
|
beta-site APP-cleaving enzyme 2
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAMBI
|
BMP and activin membrane-bound inhibitor
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BBS1
|
Bardet-Biedl syndrome 1
|
|
BBS4
|
Bardet-Biedl syndrome 4
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L12
|
BCL2-like 12 (proline rich)
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEST1
|
bestrophin 1
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BHLHE41
|
basic helix-loop-helix family, member e41
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BLOC1S4
|
biogenesis of lysosomal organelles complex-1, subunit 4, cappuccino
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP5
|
bone morphogenetic protein 5
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BPI
|
bactericidal/permeability-increasing protein
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BRS3
|
bombesin-like receptor 3
|
|
BSG
|
basigin (Ok blood group)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTG1
|
B-cell translocation gene 1, anti-proliferative
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
C1QTNF3
|
C1q and tumor necrosis factor related protein 3
|
|
C2CD2
|
C2 calcium-dependent domain containing 2
|
|
C2CD4B
|
C2 calcium-dependent domain containing 4B
|
|
C3
|
complement component 3
|
|
C5
|
complement component 5
|
|
C5AR1
|
complement component 5a receptor 1
|
|
CA12
|
carbonic anhydrase XII
|
|
CA2
|
carbonic anhydrase II
|
|
CA9
|
carbonic anhydrase IX
|
|
CAB39L
|
calcium binding protein 39-like
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CACNG2
|
calcium channel, voltage-dependent, gamma subunit 2
|
|
CALB2
|
calbindin 2
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CALR
|
calreticulin
|
|
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CANX
|
calnexin
|
|
CAP1
|
CAP, adenylate cyclase-associated protein 1 (yeast)
|
|
CAPG
|
capping protein (actin filament), gelsolin-like
|
|
CAPN10
|
calpain 10
|
|
CARD18
|
caspase recruitment domain family, member 18
|
|
CARM1
|
coactivator-associated arginine methyltransferase 1
|
|
CASP12
|
caspase 12 (gene/pseudogene)
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP8AP2
|
caspase 8 associated protein 2
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBFB
|
core-binding factor, beta subunit
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBLL1
|
Cbl proto-oncogene-like 1, E3 ubiquitin protein ligase
|
|
CBR1
|
carbonyl reductase 1
|
|
CBR3
|
carbonyl reductase 3
|
|
CBX1
|
chromobox homolog 1
|
|
CCK
|
cholecystokinin
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL16
|
chemokine (C-C motif) ligand 16
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL24
|
chemokine (C-C motif) ligand 24
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCL8
|
chemokine (C-C motif) ligand 8
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR4
|
chemokine (C-C motif) receptor 4
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
|
CD14
|
CD14 molecule
|
|
CD177
|
CD177 molecule
|
|
CD19
|
CD19 molecule
|
|
CD1A
|
CD1a molecule
|
|
CD1B
|
CD1b molecule
|
|
CD1C
|
CD1c molecule
|
|
CD1D
|
CD1d molecule
|
|
CD200
|
CD200 molecule
|
|
CD209
|
CD209 molecule
|
|
CD24
|
CD24 molecule
|
|
CD27
|
CD27 molecule
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD3EAP
|
CD3e molecule, epsilon associated protein
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD52
|
CD52 molecule
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD68
|
CD68 molecule
|
|
CD70
|
CD70 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD80
|
CD80 molecule
|
|
CD81
|
CD81 molecule
|
|
CD83
|
CD83 molecule
|
|
CD84
|
CD84 molecule
|
|
CD9
|
CD9 molecule
|
|
CDA
|
cytidine deaminase
|
|
CDC25A
|
cell division cycle 25A
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK10
|
cyclin-dependent kinase 10
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN3
|
cyclin-dependent kinase inhibitor 3
|
|
CDNF
|
cerebral dopamine neurotrophic factor
|
|
CDR1
|
cerebellar degeneration-related protein 1, 34kDa
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CECR1
|
cat eye syndrome chromosome region, candidate 1
|
|
CENPH
|
centromere protein H
|
|
CENPW
|
centromere protein W
|
|
CEP55
|
centrosomal protein 55kDa
|
|
CES1
|
carboxylesterase 1
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFP
|
complement factor properdin
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CGRRF1
|
cell growth regulator with ring finger domain 1
|
|
CHAT
|
choline O-acetyltransferase
|
|
CHD1L
|
chromodomain helicase DNA binding protein 1-like
|
|
CHD8
|
chromodomain helicase DNA binding protein 8
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHGB
|
chromogranin B
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHKA
|
choline kinase alpha
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHRNA9
|
cholinergic receptor, nicotinic, alpha 9 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CHRNE
|
cholinergic receptor, nicotinic, epsilon (muscle)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIAPIN1
|
cytokine induced apoptosis inhibitor 1
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CIRBP
|
cold inducible RNA binding protein
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
CKB
|
creatine kinase, brain
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
|
CLDN1
|
claudin 1
|
|
CLDN11
|
claudin 11
|
|
CLDN14
|
claudin 14
|
|
CLDN16
|
claudin 16
|
|
CLDN3
|
claudin 3
|
|
CLDN6
|
claudin 6
|
|
CLEC4A
|
C-type lectin domain family 4, member A
|
|
CLOCK
|
clock circadian regulator
|
|
CLU
|
clusterin
|
|
CMPK1
|
cytidine monophosphate (UMP-CMP) kinase 1, cytosolic
|
|
CNN2
|
calponin 2
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CNTF
|
ciliary neurotrophic factor
|
|
CNTFR
|
ciliary neurotrophic factor receptor
|
|
CNTN2
|
contactin 2 (axonal)
|
|
COG2
|
component of oligomeric golgi complex 2
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COL5A2
|
collagen, type V, alpha 2
|
|
COMT
|
catechol-O-methyltransferase
|
|
COQ10A
|
coenzyme Q10 homolog A (S. cerevisiae)
|
|
COQ2
|
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CRABP1
|
cellular retinoic acid binding protein 1
|
|
CRBN
|
cereblon
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREB3
|
cAMP responsive element binding protein 3
|
|
CREBBP
|
CREB binding protein
|
|
CREM
|
cAMP responsive element modulator
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CRLS1
|
cardiolipin synthase 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CST3
|
cystatin C
|
|
CSTA
|
cystatin A (stefin A)
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTAG2
|
cancer/testis antigen 2
|
|
CTBP2
|
C-terminal binding protein 2
|
|
CTCFL
|
CCCTC-binding factor (zinc finger protein)-like
|
|
CTF1
|
cardiotrophin 1
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNAL1
|
catenin (cadherin-associated protein), alpha-like 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTSA
|
cathepsin A
|
|
CTSB
|
cathepsin B
|
|
CTSD
|
cathepsin D
|
|
CUBN
|
cubilin (intrinsic factor-cobalamin receptor)
|
|
CUEDC2
|
CUE domain containing 2
|
|
CUL4A
|
cullin 4A
|
|
CUX1
|
cut-like homeobox 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYCS
|
cytochrome c, somatic
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2R1
|
cytochrome P450, family 2, subfamily R, polypeptide 1
|
|
CYP2W1
|
cytochrome P450, family 2, subfamily W, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
CYSLTR2
|
cysteinyl leukotriene receptor 2
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DAXX
|
death-domain associated protein
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DBT
|
dihydrolipoamide branched chain transacylase E2
|
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCLK1
|
doublecortin-like kinase 1
|
|
DDB2
|
damage-specific DNA binding protein 2, 48kDa
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked
|
|
DDX43
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 43
|
|
DDX5
|
DEAD (Asp-Glu-Ala-Asp) box helicase 5
|
|
DEC1
|
deleted in esophageal cancer 1
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEL22Q11.2
|
Chromosome 22q11.2 deletion syndrome, distal
|
|
DFFA
|
DNA fragmentation factor, 45kDa, alpha polypeptide
|
|
DGAT1
|
diacylglycerol O-acyltransferase 1
|
|
DGAT2
|
diacylglycerol O-acyltransferase 2
|
|
DGKE
|
diacylglycerol kinase, epsilon 64kDa
|
|
DHFR
|
dihydrofolate reductase
|
|
DHODH
|
dihydroorotate dehydrogenase (quinone)
|
|
DHPS
|
deoxyhypusine synthase
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DIAPH1
|
diaphanous-related formin 1
|
|
DIO3
|
deiodinase, iodothyronine, type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKC1
|
dyskeratosis congenita 1, dyskerin
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLGAP3
|
discs, large (Drosophila) homolog-associated protein 3
|
|
DMD
|
dystrophin
|
|
DNAJC3
|
DnaJ (Hsp40) homolog, subfamily C, member 3
|
|
DNM1
|
dynamin 1
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOK7
|
docking protein 7
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
DRD5
|
dopamine receptor D5
|
|
DSG2
|
desmoglein 2
|
|
DSG3
|
desmoglein 3
|
|
DSP
|
desmoplakin
|
|
DTL
|
denticleless E3 ubiquitin protein ligase homolog (Drosophila)
|
|
DTX3L
|
deltex 3 like, E3 ubiquitin ligase
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP21
|
dual specificity phosphatase 21
|
|
DYSF
|
dysferlin
|
|
DZIP1
|
DAZ interacting zinc finger protein 1
|
|
E2F1
|
E2F transcription factor 1
|
|
EBI3
|
Epstein-Barr virus induced 3
|
|
ECT2
|
epithelial cell transforming 2
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2
|
|
EEF2
|
eukaryotic translation elongation factor 2
|
|
EEF2K
|
eukaryotic elongation factor 2 kinase
|
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
|
EGR1
|
early growth response 1
|
|
EHD2
|
EH-domain containing 2
|
|
EIF2A
|
eukaryotic translation initiation factor 2A, 65kDa
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF3A
|
eukaryotic translation initiation factor 3, subunit A
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ELN
|
elastin
|
|
ELOVL6
|
ELOVL fatty acid elongase 6
|
|
EMILIN2
|
elastin microfibril interfacer 2
|
|
EML4
|
echinoderm microtubule associated protein like 4
|
|
EMP2
|
epithelial membrane protein 2
|
|
ENDOG
|
endonuclease G
|
|
ENG
|
endoglin
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA2
|
EPH receptor A2
|
|
EPHB4
|
EPH receptor B4
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
EREG
|
epiregulin
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ERO1L
|
ERO1-like (S. cerevisiae)
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRP1
|
epithelial splicing regulatory protein 1
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ESRRG
|
estrogen-related receptor gamma
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
ETV6
|
ets variant 6
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EXOSC5
|
exosome component 5
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F10
|
coagulation factor X
|
|
F11
|
coagulation factor XI
|
|
F11R
|
F11 receptor
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL2
|
coagulation factor II (thrombin) receptor-like 2
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP1
|
fatty acid binding protein 1, liver
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FAM175A
|
family with sequence similarity 175, member A
|
|
FAM46C
|
family with sequence similarity 46, member C
|
|
FAM57A
|
family with sequence similarity 57, member A
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGBP
|
Fc fragment of IgG binding protein
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR2C
|
Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FCN3
|
ficolin (collagen/fibrinogen domain containing) 3
|
|
FCRLB
|
Fc receptor-like B
|
|
FDPS
|
farnesyl diphosphate synthase
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FES
|
FES proto-oncogene, tyrosine kinase
|
|
FFAR1
|
free fatty acid receptor 1
|
|
FGB
|
fibrinogen beta chain
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FGG
|
fibrinogen gamma chain
|
|
FGR
|
FGR proto-oncogene, Src family tyrosine kinase
|
|
FHIT
|
fragile histidine triad
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLCN
|
folliculin
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLNA
|
filamin A, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FMO3
|
flavin containing monooxygenase 3
|
|
FN1
|
fibronectin 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOLR2
|
folate receptor 2 (fetal)
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXA1
|
forkhead box A1
|
|
FOXC2
|
forkhead box C2
|
|
FOXJ1
|
forkhead box J1
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FOXP3
|
forkhead box P3
|
|
FRZB
|
frizzled-related protein
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FST
|
follistatin
|
|
FSTL1
|
follistatin-like 1
|
|
FTL
|
ferritin, light polypeptide
|
|
FTO
|
fat mass and obesity associated
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FXN
|
frataxin
|
|
FZD1
|
frizzled class receptor 1
|
|
FZD8
|
frizzled class receptor 8
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAA
|
glucosidase, alpha; acid
|
|
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
|
GABRA6
|
gamma-aminobutyric acid (GABA) A receptor, alpha 6
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GADL1
|
glutamate decarboxylase-like 1
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GALNT3
|
polypeptide N-acetylgalactosaminyltransferase 3
|
|
GALNT8
|
polypeptide N-acetylgalactosaminyltransferase 8
|
|
GALR1
|
galanin receptor 1
|
|
GAST
|
gastrin
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA3
|
GATA binding protein 3
|
|
GATA4
|
GATA binding protein 4
|
|
GBA
|
glucosidase, beta, acid
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GCG
|
glucagon
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
|
GCLC
|
glutamate-cysteine ligase, catalytic subunit
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF5
|
growth differentiation factor 5
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GFER
|
growth factor, augmenter of liver regeneration
|
|
GFI1
|
growth factor independent 1 transcription repressor
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIPC1
|
GIPC PDZ domain containing family, member 1
|
|
GIPR
|
gastric inhibitory polypeptide receptor
|
|
GIT2
|
G protein-coupled receptor kinase interacting ArfGAP 2
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJC2
|
gap junction protein, gamma 2, 47kDa
|
|
GLCCI1
|
glucocorticoid induced 1
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI2
|
GLI family zinc finger 2
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GLS
|
glutaminase
|
|
GLS2
|
glutaminase 2 (liver, mitochondrial)
|
|
GM2A
|
GM2 ganglioside activator
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GNA15
|
guanine nucleotide binding protein (G protein), alpha 15 (Gq class)
|
|
GNAI2
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2
|
|
GNB1
|
guanine nucleotide binding protein (G protein), beta polypeptide 1
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNG2
|
guanine nucleotide binding protein (G protein), gamma 2
|
|
GNL3
|
guanine nucleotide binding protein-like 3 (nucleolar)
|
|
GNLY
|
granulysin
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GOLGA2
|
golgin A2
|
|
GOLM1
|
golgi membrane protein 1
|
|
GP2
|
glycoprotein 2 (zymogen granule membrane)
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GPC3
|
glypican 3
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPI
|
glucose-6-phosphate isomerase
|
|
GPR55
|
G protein-coupled receptor 55
|
|
GPX1
|
glutathione peroxidase 1
|
|
GREB1
|
growth regulation by estrogen in breast cancer 1
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRIA4
|
glutamate receptor, ionotropic, AMPA 4
|
|
GRIK1
|
glutamate receptor, ionotropic, kainate 1
|
|
GRIK4
|
glutamate receptor, ionotropic, kainate 4
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRK5
|
G protein-coupled receptor kinase 5
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GRM2
|
glutamate receptor, metabotropic 2
|
|
GRM3
|
glutamate receptor, metabotropic 3
|
|
GRM4
|
glutamate receptor, metabotropic 4
|
|
GRM5
|
glutamate receptor, metabotropic 5
|
|
GRN
|
granulin
|
|
GRP
|
gastrin-releasing peptide
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSS
|
glutathione synthetase
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GSTZ1
|
glutathione S-transferase zeta 1
|
|
GUCY2C
|
guanylate cyclase 2C
|
|
GYS1
|
glycogen synthase 1 (muscle)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H2AFX
|
H2A histone family, member X
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAPLN1
|
hyaluronan and proteoglycan link protein 1
|
|
HAPLN3
|
hyaluronan and proteoglycan link protein 3
|
|
HAS1
|
hyaluronan synthase 1
|
|
HAS2
|
hyaluronan synthase 2
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBB
|
hemoglobin, beta
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HCN1
|
hyperpolarization activated cyclic nucleotide gated potassium channel 1
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC4
|
histone deacetylase 4
|
|
HDAC6
|
histone deacetylase 6
|
|
HDGF
|
hepatoma-derived growth factor
|
|
HEXA
|
hexosaminidase A (alpha polypeptide)
|
|
HEXB
|
hexosaminidase B (beta polypeptide)
|
|
HEY1
|
hes-related family bHLH transcription factor with YRPW motif 1
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HGS
|
hepatocyte growth factor-regulated tyrosine kinase substrate
|
|
HHIP
|
hedgehog interacting protein
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIP1
|
huntingtin interacting protein 1
|
|
HIST1H1C
|
histone cluster 1, H1c
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMBS
|
hydroxymethylbilane synthase
|
|
HMCN1
|
hemicentin 1
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGB1
|
high mobility group box 1
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HMGN5
|
high mobility group nucleosome binding domain 5
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HOMER1
|
homer scaffolding protein 1
|
|
HOXA10
|
homeobox A10
|
|
HOXB13
|
homeobox B13
|
|
HOXD9
|
homeobox D9
|
|
HP
|
haptoglobin
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HPS1
|
Hermansky-Pudlak syndrome 1
|
|
HPS6
|
Hermansky-Pudlak syndrome 6
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH1
|
histamine receptor H1
|
|
HRH2
|
histamine receptor H2
|
|
HRH3
|
histamine receptor H3
|
|
HRH4
|
histamine receptor H4
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B12
|
hydroxysteroid (17-beta) dehydrogenase 12
|
|
HSD17B14
|
hydroxysteroid (17-beta) dehydrogenase 14
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSD17B4
|
hydroxysteroid (17-beta) dehydrogenase 4
|
|
HSD17B8
|
hydroxysteroid (17-beta) dehydrogenase 8
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB8
|
heat shock 22kDa protein 8
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
HTATIP2
|
HIV-1 Tat interactive protein 2, 30kDa
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTR3A
|
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
|
|
HTR3B
|
5-hydroxytryptamine (serotonin) receptor 3B, ionotropic
|
|
HTR5A
|
5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTRA4
|
HtrA serine peptidase 4
|
|
HTT
|
huntingtin
|
|
HUS1
|
HUS1 checkpoint homolog (S. pombe)
|
|
IAPP
|
islet amyloid polypeptide
|
|
IBSP
|
integrin-binding sialoprotein
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3
|
|
IFITM3
|
interferon induced transmembrane protein 3
|
|
IFN1@
|
interferon, type 1, cluster
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNL2
|
interferon, lambda 2
|
|
IFNL3
|
interferon, lambda 3
|
|
IFNL4
|
interferon, lambda 4 (gene/pseudogene)
|
|
IFT38
|
intraflagellar transport 38
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP4
|
insulin-like growth factor binding protein 4
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IKBKAP
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL11
|
interleukin 11
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL13
|
interleukin 13
|
|
IL13RA2
|
interleukin 13 receptor, alpha 2
|
|
IL15
|
interleukin 15
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL18BP
|
interleukin 18 binding protein
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1R2
|
interleukin 1 receptor, type II
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL20
|
interleukin 20
|
|
IL21
|
interleukin 21
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL24
|
interleukin 24
|
|
IL25
|
interleukin 25
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL3
|
interleukin 3
|
|
IL32
|
interleukin 32
|
|
IL33
|
interleukin 33
|
|
IL33R
|
interleukin 33 receptor
|
|
IL36A
|
interleukin 36, alpha
|
|
IL37
|
interleukin 37
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL4
|
interleukin 4
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9R
|
interleukin 9 receptor
|
|
ILK
|
integrin-linked kinase
|
|
ING1
|
inhibitor of growth family, member 1
|
|
ING4
|
inhibitor of growth family, member 4
|
|
INHA
|
inhibin, alpha
|
|
INHBB
|
inhibin, beta B
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INS
|
insulin
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
INSM1
|
insulinoma-associated 1
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF2
|
interferon regulatory factor 2
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF9
|
interferon regulatory factor 9
|
|
IRGM
|
immunity-related GTPase family, M
|
|
IRS2
|
insulin receptor substrate 2
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGAD
|
integrin, alpha D
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB4
|
integrin, beta 4
|
|
ITGB5
|
integrin, beta 5
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
IVL
|
involucrin
|
|
JAG1
|
jagged 1
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
KAT2A
|
K(lysine) acetyltransferase 2A
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ1
|
potassium channel, inwardly rectifying subfamily J, member 1
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNJ6
|
potassium channel, inwardly rectifying subfamily J, member 6
|
|
KCNK2
|
potassium channel, two pore domain subfamily K, member 2
|
|
KCNK9
|
potassium channel, two pore domain subfamily K, member 9
|
|
KCNMB1
|
potassium channel subfamily M regulatory beta subunit 1
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM3A
|
lysine (K)-specific demethylase 3A
|
|
KDM4C
|
lysine (K)-specific demethylase 4C
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
KIAA1524
|
KIAA1524
|
|
KIF5B
|
kinesin family member 5B
|
|
KIF6
|
kinesin family member 6
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR2DS3
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3
|
|
KIR2DS4
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
|
|
KIR3DS1
|
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KISS1R
|
KISS1 receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KL
|
klotho
|
|
KLF10
|
Kruppel-like factor 10
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLHDC1
|
kelch domain containing 1
|
|
KLHL1
|
kelch-like family member 1
|
|
KLK11
|
kallikrein-related peptidase 11
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK5
|
kallikrein-related peptidase 5
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KMT2E
|
lysine (K)-specific methyltransferase 2E
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT12
|
keratin 12, type I
|
|
KRT17
|
keratin 17, type I
|
|
KRT18
|
keratin 18, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT8
|
keratin 8, type II
|
|
KRTAP11-1
|
keratin associated protein 11-1
|
|
KRTAP13-2
|
keratin associated protein 13-2
|
|
KRTAP13-4
|
keratin associated protein 13-4
|
|
KRTAP19-5
|
keratin associated protein 19-5
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAMC2
|
laminin, gamma 2
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCN2
|
lipocalin 2
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LETMD1
|
LETM1 domain containing 1
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS3BP
|
lectin, galactoside-binding, soluble, 3 binding protein
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIF
|
leukemia inhibitory factor
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LILRA3
|
leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3
|
|
LILRB4
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
|
|
LIMK2
|
LIM domain kinase 2
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LIPG
|
lipase, endothelial
|
|
LMNA
|
lamin A/C
|
|
LMNB1
|
lamin B1
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LNX2
|
ligand of numb-protein X 2
|
|
LOC100128356
|
protein transactivated by hepatitis B virus E antigen
|
|
LOX
|
lysyl oxidase
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPAR2
|
lysophosphatidic acid receptor 2
|
|
LPAR3
|
lysophosphatidic acid receptor 3
|
|
LPIN1
|
lipin 1
|
|
LPL
|
lipoprotein lipase
|
|
LRG1
|
leucine-rich alpha-2-glycoprotein 1
|
|
LRP2
|
low density lipoprotein receptor-related protein 2
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA
|
lymphotoxin alpha
|
|
LTB4R
|
leukotriene B4 receptor
|
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3)
|
|
LY6K
|
lymphocyte antigen 6 complex, locus K
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAD1L1
|
MAD1 mitotic arrest deficient-like 1 (yeast)
|
|
MAD2L2
|
MAD2 mitotic arrest deficient-like 2 (yeast)
|
|
MAFF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F
|
|
MAGEA1
|
melanoma antigen family A1
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAGED2
|
melanoma antigen family D2
|
|
MALT1
|
MALT1 paracaspase
|
|
MAML1
|
mastermind-like 1 (Drosophila)
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAP1LC3B
|
microtubule-associated protein 1 light chain 3 beta
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K3
|
mitogen-activated protein kinase kinase 3
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP2K6
|
mitogen-activated protein kinase kinase 6
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK11
|
mitogen-activated protein kinase 11
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARCH9
|
membrane-associated ring finger (C3HC4) 9
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor)
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC2R
|
melanocortin 2 receptor (adrenocorticotropic hormone)
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCHR1
|
melanin-concentrating hormone receptor 1
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED1
|
mediator complex subunit 1
|
|
MEFV
|
Mediterranean fever
|
|
MELK
|
maternal embryonic leucine zipper kinase
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFAP2
|
microfibrillar-associated protein 2
|
|
MFAP5
|
microfibrillar associated protein 5
|
|
MFGE8
|
milk fat globule-EGF factor 8 protein
|
|
MFN2
|
mitofusin 2
|
|
MFSD12
|
major facilitator superfamily domain containing 12
|
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MGRN1
|
mahogunin ring finger 1, E3 ubiquitin protein ligase
|
|
MIA
|
melanoma inhibitory activity
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICAL2
|
microtubule associated monooxygenase, calponin and LIM domain containing 2
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR107
|
microRNA 107
|
|
MIR10B
|
microRNA 10b
|
|
MIR122
|
microRNA 122
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR126
|
microRNA 126
|
|
MIR1275
|
microRNA 1275
|
|
MIR133A1
|
microRNA 133a-1
|
|
MIR135B
|
microRNA 135b
|
|
MIR137
|
microRNA 137
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR146B
|
microRNA 146b
|
|
MIR152
|
microRNA 152
|
|
MIR153-1
|
microRNA 153-1
|
|
MIR155
|
microRNA 155
|
|
MIR15A
|
microRNA 15a
|
|
MIR15B
|
microRNA 15b
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR17
|
microRNA 17
|
|
MIR17HG
|
miR-17-92 cluster host gene
|
|
MIR181A1
|
microRNA 181a-1
|
|
MIR181A2
|
microRNA 181a-2
|
|
MIR181B1
|
microRNA 181b-1
|
|
MIR192
|
microRNA 192
|
|
MIR199A1
|
microRNA 199a-1
|
|
MIR19B1
|
microRNA 19b-1
|
|
MIR200A
|
microRNA 200a
|
|
MIR200B
|
microRNA 200b
|
|
MIR200C
|
microRNA 200c
|
|
MIR202
|
microRNA 202
|
|
MIR203A
|
microRNA 203a
|
|
MIR205
|
microRNA 205
|
|
MIR206
|
microRNA 206
|
|
MIR21
|
microRNA 21
|
|
MIR212
|
microRNA 212
|
|
MIR214
|
microRNA 214
|
|
MIR221
|
microRNA 221
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR29A
|
microRNA 29a
|
|
MIR301B
|
microRNA 301b
|
|
MIR302B
|
microRNA 302b
|
|
MIR30A
|
microRNA 30a
|
|
MIR320A
|
microRNA 320a
|
|
MIR320D1
|
microRNA 320d-1
|
|
MIR326
|
microRNA 326
|
|
MIR328
|
microRNA 328
|
|
MIR34A
|
microRNA 34a
|
|
MIR375
|
microRNA 375
|
|
MIR378A
|
microRNA 378a
|
|
MIR383
|
microRNA 383
|
|
MIR449A
|
microRNA 449a
|
|
MIR449B
|
microRNA 449b
|
|
MIR483
|
microRNA 483
|
|
MIR494
|
microRNA 494
|
|
MIR495
|
microRNA 495
|
|
MIR499A
|
microRNA 499a
|
|
MIR506
|
microRNA 506
|
|
MIR512-1
|
microRNA 512-1
|
|
MIR512-2
|
microRNA 512-2
|
|
MIR520H
|
microRNA 520h
|
|
MIR542
|
microRNA 542
|
|
MIR590
|
microRNA 590
|
|
MIR593
|
microRNA 593
|
|
MIR663A
|
microRNA 663a
|
|
MIR874
|
microRNA 874
|
|
MIR9-2
|
microRNA 9-2
|
|
MIR95
|
microRNA 95
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MIRLET7D
|
microRNA let-7d
|
|
MIRLET7G
|
microRNA let-7g
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MLANA
|
melan-A
|
|
MLH1
|
mutL homolog 1
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
|
MLXIP
|
MLX interacting protein
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP10
|
matrix metallopeptidase 10
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP19
|
matrix metallopeptidase 19
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP28
|
matrix metallopeptidase 28
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MN1
|
meningioma (disrupted in balanced translocation) 1
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPO
|
myeloperoxidase
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MRPL23
|
mitochondrial ribosomal protein L23
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MSH6
|
mutS homolog 6
|
|
MSI2
|
musashi RNA-binding protein 2
|
|
MSLN
|
mesothelin
|
|
MSN
|
moesin
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MT-ND4
|
NADH dehydrogenase, subunit 4 (complex I)
|
|
MT1B
|
metallothionein 1B
|
|
MT1E
|
metallothionein 1E
|
|
MT1G
|
metallothionein 1G
|
|
MT1H
|
metallothionein 1H
|
|
MT1L
|
metallothionein 1L (gene/pseudogene)
|
|
MT2A
|
metallothionein 2A
|
|
MTA1
|
metastasis associated 1
|
|
MTDH
|
metadherin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUSK
|
muscle, skeletal, receptor tyrosine kinase
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MX2
|
MX dynamin-like GTPase 2
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYBBP1A
|
MYB binding protein (P160) 1a
|
|
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYO18B
|
myosin XVIIIB
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NANOG
|
Nanog homeobox
|
|
NAP1L1
|
nucleosome assembly protein 1-like 1
|
|
NASP
|
nuclear autoantigenic sperm protein (histone-binding)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NDRG4
|
NDRG family member 4
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NEK4
|
NIMA-related kinase 4
|
|
NEK6
|
NIMA-related kinase 6
|
|
NES
|
nestin
|
|
NET1
|
neuroepithelial cell transforming 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NEXN
|
nexilin (F actin binding protein)
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFE2
|
nuclear factor, erythroid 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NHEJ1
|
nonhomologous end-joining factor 1
|
|
NINL
|
ninein-like
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NLRP10
|
NLR family, pyrin domain containing 10
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NMI
|
N-myc (and STAT) interactor
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOG
|
noggin
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NOX4
|
NADPH oxidase 4
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPC2
|
Niemann-Pick disease, type C2
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NPPC
|
natriuretic peptide C
|
|
NPY
|
neuropeptide Y
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NRG4
|
neuregulin 4
|
|
NRIP1
|
nuclear receptor interacting protein 1
|
|
NRP1
|
neuropilin 1
|
|
NRXN1
|
neurexin 1
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NTF3
|
neurotrophin 3
|
|
NTN1
|
netrin 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUCB2
|
nucleobindin 2
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
NUP153
|
nucleoporin 153kDa
|
|
NUP88
|
nucleoporin 88kDa
|
|
NUP98
|
nucleoporin 98kDa
|
|
NXF1
|
nuclear RNA export factor 1
|
|
NXNL1
|
nucleoredoxin-like 1
|
|
OASL
|
2'-5'-oligoadenylate synthetase-like
|
|
OAT
|
ornithine aminotransferase
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OFD1
|
oral-facial-digital syndrome 1
|
|
OGFR
|
opioid growth factor receptor
|
|
OGT
|
O-linked N-acetylglucosamine (GlcNAc) transferase
|
|
OLFM4
|
olfactomedin 4
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OMA1
|
OMA1 zinc metallopeptidase
|
|
ONECUT1
|
one cut homeobox 1
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OPRD1
|
opioid receptor, delta 1
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OR51E1
|
olfactory receptor, family 51, subfamily E, member 1
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
ORMDL3
|
ORMDL sphingolipid biosynthesis regulator 3
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
OXTR
|
oxytocin receptor
|
|
P2RX3
|
purinergic receptor P2X, ligand gated ion channel, 3
|
|
P2RX5
|
purinergic receptor P2X, ligand gated ion channel, 5
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PANX1
|
pannexin 1
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARG
|
poly (ADP-ribose) glycohydrolase
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PARP14
|
poly (ADP-ribose) polymerase family, member 14
|
|
PARP9
|
poly (ADP-ribose) polymerase family, member 9
|
|
PASK
|
PAS domain containing serine/threonine kinase
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PAX2
|
paired box 2
|
|
PAX8
|
paired box 8
|
|
PAXBP1
|
PAX3 and PAX7 binding protein 1
|
|
PAXIP1
|
PAX interacting (with transcription-activation domain) protein 1
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCP4
|
Purkinje cell protein 4
|
|
PCSK6
|
proprotein convertase subtilisin/kexin type 6
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD5
|
programmed cell death 5
|
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited
|
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PDE9A
|
phosphodiesterase 9A
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFD
|
platelet derived growth factor D
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDIA3
|
protein disulfide isomerase family A, member 3
|
|
PDLIM5
|
PDZ and LIM domain 5
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PDYN
|
prodynorphin
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PEBP4
|
phosphatidylethanolamine-binding protein 4
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PER1
|
period circadian clock 1
|
|
PER2
|
period circadian clock 2
|
|
PER3
|
period circadian clock 3
|
|
PES1
|
pescadillo ribosomal biogenesis factor 1
|
|
PFN1
|
profilin 1
|
|
PGF
|
placental growth factor
|
|
PGK1
|
phosphoglycerate kinase 1
|
|
PGR
|
progesterone receptor
|
|
PHB
|
prohibitin
|
|
PHF8
|
PHD finger protein 8
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PIR
|
pirin (iron-binding nuclear protein)
|
|
PKIB
|
protein kinase (cAMP-dependent, catalytic) inhibitor beta
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAC1
|
placenta-specific 1
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PLCD1
|
phospholipase C, delta 1
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLEKHA6
|
pleckstrin homology domain containing, family A member 6
|
|
PLIN1
|
perilipin 1
|
|
PLK1
|
polo-like kinase 1
|
|
PLK2
|
polo-like kinase 2
|
|
PLS3
|
plastin 3
|
|
PLTP
|
phospholipid transfer protein
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PMEL
|
premelanosome protein
|
|
PMF1
|
polyamine-modulated factor 1
|
|
PML
|
promyelocytic leukemia
|
|
PMM2
|
phosphomannomutase 2
|
|
PNLIP
|
pancreatic lipase
|
|
PNMT
|
phenylethanolamine N-methyltransferase
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
PODXL
|
podocalyxin-like
|
|
POLD2P1
|
polymerase (DNA directed), delta 2, accessory subunit pseudogene 1
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POLI
|
polymerase (DNA directed) iota
|
|
POLK
|
polymerase (DNA directed) kappa
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
PON1
|
paraoxonase 1
|
|
PON3
|
paraoxonase 3
|
|
POR
|
P450 (cytochrome) oxidoreductase
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PPID
|
peptidylprolyl isomerase D
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP1R2
|
protein phosphatase 1, regulatory (inhibitor) subunit 2
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R5A
|
protein phosphatase 2, regulatory subunit B', alpha
|
|
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma
|
|
PPY
|
pancreatic polypeptide
|
|
PRAM1
|
PML-RARA regulated adaptor molecule 1
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRCP
|
prolylcarboxypeptidase (angiotensinase C)
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRDX4
|
peroxiredoxin 4
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
|
PRKAR2A
|
protein kinase, cAMP-dependent, regulatory, type II, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD2
|
protein kinase D2
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROK1
|
prokineticin 1
|
|
PROM1
|
prominin 1
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
|
PRR11
|
proline rich 11
|
|
PRRC2C
|
proline-rich coiled-coil 2C
|
|
PRSS8
|
protease, serine, 8
|
|
PRTN3
|
proteinase 3
|
|
PSCA
|
prostate stem cell antigen
|
|
PSEN1
|
presenilin 1
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PSMB5
|
proteasome (prosome, macropain) subunit, beta type, 5
|
|
PSMC3
|
proteasome (prosome, macropain) 26S subunit, ATPase, 3
|
|
PSTPIP1
|
proline-serine-threonine phosphatase interacting protein 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDR
|
prostaglandin D2 receptor (DP)
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGFR
|
prostaglandin F receptor (FP)
|
|
PTGFRN
|
prostaglandin F2 receptor inhibitor
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTK7
|
protein tyrosine kinase 7 (inactive)
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPRA
|
protein tyrosine phosphatase, receptor type, A
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PTTG1IP
|
pituitary tumor-transforming 1 interacting protein
|
|
QDPR
|
quinoid dihydropteridine reductase
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAB6A
|
RAB6A, member RAS oncogene family
|
|
RABL3
|
RAB, member of RAS oncogene family-like 3
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD23B
|
RAD23 homolog B (S. cerevisiae)
|
|
RAD51
|
RAD51 recombinase
|
|
RAD9A
|
RAD9 homolog A (S. pombe)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAG2
|
recombination activating gene 2
|
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related)
|
|
RALBP1
|
ralA binding protein 1
|
|
RALGAPA2
|
Ral GTPase activating protein, alpha subunit 2 (catalytic)
|
|
RAP2B
|
RAP2B, member of RAS oncogene family
|
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6
|
|
RB1
|
retinoblastoma 1
|
|
RB1CC1
|
RB1-inducible coiled-coil 1
|
|
RBM15
|
RNA binding motif protein 15
|
|
RBM3
|
RNA binding motif (RNP1, RRM) protein 3
|
|
RBM39
|
RNA binding motif protein 39
|
|
RBP2
|
retinol binding protein 2, cellular
|
|
RBPMS
|
RNA binding protein with multiple splicing
|
|
RDX
|
radixin
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
REEP5
|
receptor accessory protein 5
|
|
REG3A
|
regenerating islet-derived 3 alpha
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
RELN
|
reelin
|
|
REN
|
renin
|
|
REPS1
|
RALBP1 associated Eps domain containing 1
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RFX5
|
regulatory factor X, 5 (influences HLA class II expression)
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RGS5
|
regulator of G-protein signaling 5
|
|
RHD
|
Rh blood group, D antigen
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RIN1
|
Ras and Rab interactor 1
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RIPK3
|
receptor-interacting serine-threonine kinase 3
|
|
RLBP1
|
retinaldehyde binding protein 1
|
|
RLN1
|
relaxin 1
|
|
RLN2
|
relaxin 2
|
|
RND3
|
Rho family GTPase 3
|
|
RNF216
|
ring finger protein 216
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
RORA
|
RAR-related orphan receptor A
|
|
RORC
|
RAR-related orphan receptor C
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RPGRIP1
|
retinitis pigmentosa GTPase regulator interacting protein 1
|
|
RPL23
|
ribosomal protein L23
|
|
RPL5
|
ribosomal protein L5
|
|
RPS2
|
ribosomal protein S2
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RRAS
|
related RAS viral (r-ras) oncogene homolog
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RRM2
|
ribonucleotide reductase M2
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RUVBL2
|
RuvB-like AAA ATPase 2
|
|
RWDD2B
|
RWD domain containing 2B
|
|
RXFP1
|
relaxin/insulin-like family peptide receptor 1
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RYBP
|
RING1 and YY1 binding protein
|
|
S100A1
|
S100 calcium binding protein A1
|
|
S100A10
|
S100 calcium binding protein A10
|
|
S100A12
|
S100 calcium binding protein A12
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
SAA1
|
serum amyloid A1
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SAMD9
|
sterile alpha motif domain containing 9
|
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCG2
|
secretogranin II
|
|
SCIN
|
scinderin
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SCTR
|
secretin receptor
|
|
SDC1
|
syndecan 1
|
|
SDC4
|
syndecan 4
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SELE
|
selectin E
|
|
SELENBP1
|
selenium binding protein 1
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SELPLG
|
selectin P ligand
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SEMA5A
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA12
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
|
|
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SERPINI1
|
serpin peptidase inhibitor, clade I (neuroserpin), member 1
|
|
SERTAD1
|
SERTA domain containing 1
|
|
SET
|
SET nuclear proto-oncogene
|
|
SETDB1
|
SET domain, bifurcated 1
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFN
|
stratifin
|
|
SFPQ
|
splicing factor proline/glutamine-rich
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFTPA1
|
surfactant protein A1
|
|
SFTPA2
|
surfactant protein A2
|
|
SFTPB
|
surfactant protein B
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SGSH
|
N-sulfoglucosamine sulfohydrolase
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHC3
|
SHC (Src homology 2 domain containing) transforming protein 3
|
|
SHH
|
sonic hedgehog
|
|
SHOX
|
short stature homeobox
|
|
SIAH1
|
siah E3 ubiquitin protein ligase 1
|
|
SIGLEC12
|
sialic acid binding Ig-like lectin 12 (gene/pseudogene)
|
|
SIGLEC7
|
sialic acid binding Ig-like lectin 7
|
|
SIN3B
|
SIN3 transcription regulator family member B
|
|
SIRT1
|
sirtuin 1
|
|
SIRT2
|
sirtuin 2
|
|
SIX1
|
SIX homeobox 1
|
|
SIX2
|
SIX homeobox 2
|
|
SKP1
|
S-phase kinase-associated protein 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLAMF7
|
SLAM family member 7
|
|
SLC10A1
|
solute carrier family 10 (sodium/bile acid cotransporter), member 1
|
|
SLC11A2
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SLC22A16
|
solute carrier family 22 (organic cation/carnitine transporter), member 16
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC23A2
|
solute carrier family 23 (ascorbic acid transporter), member 2
|
|
SLC25A27
|
solute carrier family 25, member 27
|
|
SLC25A5
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5
|
|
SLC28A1
|
solute carrier family 28 (concentrative nucleoside transporter), member 1
|
|
SLC28A2
|
solute carrier family 28 (concentrative nucleoside transporter), member 2
|
|
SLC28A3
|
solute carrier family 28 (concentrative nucleoside transporter), member 3
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC2A5
|
solute carrier family 2 (facilitated glucose/fructose transporter), member 5
|
|
SLC30A4
|
solute carrier family 30 (zinc transporter), member 4
|
|
SLC31A1
|
solute carrier family 31 (copper transporter), member 1
|
|
SLC38A1
|
solute carrier family 38, member 1
|
|
SLC38A2
|
solute carrier family 38, member 2
|
|
SLC38A4
|
solute carrier family 38, member 4
|
|
SLC39A4
|
solute carrier family 39 (zinc transporter), member 4
|
|
SLC44A1
|
solute carrier family 44 (choline transporter), member 1
|
|
SLC44A2
|
solute carrier family 44 (choline transporter), member 2
|
|
SLC44A4
|
solute carrier family 44, member 4
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC5A2
|
solute carrier family 5 (sodium/glucose cotransporter), member 2
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC6A6
|
solute carrier family 6 (neurotransmitter transporter), member 6
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLCO1C1
|
solute carrier organic anion transporter family, member 1C1
|
|
SLIT3
|
slit homolog 3 (Drosophila)
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SMYD2
|
SET and MYND domain containing 2
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1)
|
|
SND1
|
staphylococcal nuclease and tudor domain containing 1
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOCS4
|
suppressor of cytokine signaling 4
|
|
SOCS7
|
suppressor of cytokine signaling 7
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SORT1
|
sortilin 1
|
|
SOST
|
sclerostin
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SPA17
|
sperm autoantigenic protein 17
|
|
SPAG5
|
sperm associated antigen 5
|
|
SPAG9
|
sperm associated antigen 9
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPHK2
|
sphingosine kinase 2
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRY4
|
sprouty homolog 4 (Drosophila)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
SRSF5
|
serine/arginine-rich splicing factor 5
|
|
SRXN1
|
sulfiredoxin 1
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
|
SSH2
|
slingshot protein phosphatase 2
|
|
SST
|
somatostatin
|
|
SSTR2
|
somatostatin receptor 2
|
|
SSTR4
|
somatostatin receptor 4
|
|
SSTR5
|
somatostatin receptor 5
|
|
SSX1
|
synovial sarcoma, X breakpoint 1
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAB2
|
stabilin 2
|
|
STAP2
|
signal transducing adaptor family member 2
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STK11
|
serine/threonine kinase 11
|
|
STMN3
|
stathmin-like 3
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
STX18
|
syntaxin 18
|
|
STX1A
|
syntaxin 1A (brain)
|
|
SUFU
|
suppressor of fused homolog (Drosophila)
|
|
SULF1
|
sulfatase 1
|
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
|
SULT1E1
|
sulfotransferase family 1E, estrogen-preferring, member 1
|
|
SULT4A1
|
sulfotransferase family 4A, member 1
|
|
SUMO2
|
small ubiquitin-like modifier 2
|
|
SUMO3
|
small ubiquitin-like modifier 3
|
|
SVEP1
|
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1
|
|
SYK
|
spleen tyrosine kinase
|
|
SYN2
|
synapsin II
|
|
SYVN1
|
synovial apoptosis inhibitor 1, synoviolin
|
|
TAAR6
|
trace amine associated receptor 6
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACR1
|
tachykinin receptor 1
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TAGLN2
|
transgelin 2
|
|
TARDBP
|
TAR DNA binding protein
|
|
TAX1BP3
|
Tax1 (human T-cell leukemia virus type I) binding protein 3
|
|
TBC1D4
|
TBC1 domain family, member 4
|
|
TBC1D7
|
TBC1 domain family, member 7
|
|
TBP
|
TATA box binding protein
|
|
TBX21
|
T-box 21
|
|
TCEAL1
|
transcription elongation factor A (SII)-like 1
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TDP2
|
tyrosyl-DNA phosphodiesterase 2
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERT
|
telomerase reverse transcriptase
|
|
TES
|
testin LIM domain protein
|
|
TF
|
transferrin
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFAP2B
|
transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
|
|
TFCP2
|
transcription factor CP2
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TFEB
|
transcription factor EB
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TFRC
|
transferrin receptor
|
|
TG
|
thyroglobulin
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
TGM1
|
transglutaminase 1
|
|
TGM2
|
transglutaminase 2
|
|
TGM5
|
transglutaminase 5
|
|
TH
|
tyrosine hydroxylase
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THBS2
|
thrombospondin 2
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TIMP4
|
TIMP metallopeptidase inhibitor 4
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TK2
|
thymidine kinase 2, mitochondrial
|
|
TKFC
|
triokinase/FMN cyclase
|
|
TLK1
|
tousled-like kinase 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR6
|
toll-like receptor 6
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TMEFF2
|
transmembrane protein with EGF-like and two follistatin-like domains 2
|
|
TMPRSS15
|
transmembrane protease, serine 15
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TMPRSS4
|
transmembrane protease, serine 4
|
|
TMSB15A
|
thymosin beta 15a
|
|
TMSB4X
|
thymosin beta 4, X-linked
|
|
TMTC1
|
transmembrane and tetratricopeptide repeat containing 1
|
|
TMTC2
|
transmembrane and tetratricopeptide repeat containing 2
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF10D
|
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TNFSF18
|
tumor necrosis factor (ligand) superfamily, member 18
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TNKS
|
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNPO3
|
transportin 3
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOPBP1
|
topoisomerase (DNA) II binding protein 1
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TOX3
|
TOX high mobility group box family member 3
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TPO
|
thyroid peroxidase
|
|
TPX2
|
TPX2, microtubule-associated
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRAF3IP2
|
TRAF3 interacting protein 2
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TREM2
|
triggering receptor expressed on myeloid cells 2
|
|
TRIM24
|
tripartite motif containing 24
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPM2
|
transient receptor potential cation channel, subfamily M, member 2
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV5
|
transient receptor potential cation channel, subfamily V, member 5
|
|
TSC22D3
|
TSC22 domain family, member 3
|
|
TSHB
|
thyroid stimulating hormone, beta
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TSPEAR
|
thrombospondin-type laminin G domain and EAR repeats
|
|
TSPO
|
translocator protein (18kDa)
|
|
TTF1
|
transcription termination factor, RNA polymerase I
|
|
TTK
|
TTK protein kinase
|
|
TTR
|
transthyretin
|
|
TUBB
|
tubulin, beta class I
|
|
TUBB2B
|
tubulin, beta 2B class IIb
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TUBB4B
|
tubulin, beta 4B class IVb
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXN
|
thioredoxin
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TXNRD1
|
thioredoxin reductase 1
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
TYR
|
tyrosinase
|
|
TYRO3
|
TYRO3 protein tyrosine kinase
|
|
UBA7
|
ubiquitin-like modifier activating enzyme 7
|
|
UBB
|
ubiquitin B
|
|
UBD
|
ubiquitin D
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UBQLN1
|
ubiquilin 1
|
|
UCA1
|
urothelial cancer associated 1 (non-protein coding)
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCN3
|
urocortin 3
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UCP3
|
uncoupling protein 3 (mitochondrial, proton carrier)
|
|
UGCG
|
UDP-glucose ceramide glucosyltransferase
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15
|
|
UHRF1
|
ubiquitin-like with PHD and ring finger domains 1
|
|
ULBP2
|
UL16 binding protein 2
|
|
URGCP
|
upregulator of cell proliferation
|
|
USO1
|
USO1 vesicle transport factor
|
|
USP18
|
ubiquitin specific peptidase 18
|
|
USP25
|
ubiquitin specific peptidase 25
|
|
USP7
|
ubiquitin specific peptidase 7 (herpes virus-associated)
|
|
UTS2
|
urotensin 2
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCAN
|
versican
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VGF
|
VGF nerve growth factor inducible
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VIP
|
vasoactive intestinal peptide
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VPS13C
|
vacuolar protein sorting 13 homolog C (S. cerevisiae)
|
|
VPS33A
|
vacuolar protein sorting 33 homolog A (S. cerevisiae)
|
|
VWF
|
von Willebrand factor
|
|
WBP1L
|
WW domain binding protein 1-like
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT11
|
wingless-type MMTV integration site family, member 11
|
|
WNT16
|
wingless-type MMTV integration site family, member 16
|
|
WNT2
|
wingless-type MMTV integration site family member 2
|
|
WNT3
|
wingless-type MMTV integration site family, member 3
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
|
WNT5B
|
wingless-type MMTV integration site family, member 5B
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
XAF1
|
XIAP associated factor 1
|
|
XBP1
|
X-box binding protein 1
|
|
XDH
|
xanthine dehydrogenase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XIRP1
|
xin actin binding repeat containing 1
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YBX3
|
Y box binding protein 3
|
|
YEATS4
|
YEATS domain containing 4
|
|
YES1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
|
YPEL3
|
yippee-like 3 (Drosophila)
|
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZBTB7A
|
zinc finger and BTB domain containing 7A
|
|
ZC3H12A
|
zinc finger CCCH-type containing 12A
|
|
ZCCHC11
|
zinc finger, CCHC domain containing 11
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZFPM1
|
zinc finger protein, FOG family member 1
|
|
ZFX
|
zinc finger protein, X-linked
|
|
ZNF326
|
zinc finger protein 326
|
|
ZNRD1
|
zinc ribbon domain containing 1
|
